
Charu Aggarwal
Director · University of Pennsylvania Health System
Credentials: · · · ·
History
- Present
Thoracic and Head & Neck Cancer Section · University of Pennsylvania Health System
2006–2008- 2003–2006
Kaleida Health System
- 1999–2003
Research
Pembrolizumab for the treatment of non-small-cell lung cancer
New England Journal of Medicine · 2015 · 5,237 citations
Journal of Clinical Oncology · 2019 · 979 citations
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 1.2020
Journal of the National Comprehensive Cancer Network · 2019 · 591 citations
- RC
77 papers

69 papers

44 papers · 3 as a fellow

41 papers · 3 as a fellow
- LS
37 papers · 6 as a fellow

34 papers · 11 as a fellow

25 papers
- JT
25 papers · 3 as a fellow
Clinical trials
- 2023–2026
Liquid Biopsy Based NGS in Newly Diagnosed NSCLC
Principal investigator · Active not recruiting
Charu Aggarwal
- 2023–2024
Principal investigator · Terminated
Abramson Cancer Center at Penn Medicine
- 2022–2028
First in Human Study of AZD9592 in Solid Tumors
Principal investigator · Active not recruiting · Phase 1
AstraZeneca
- 2021–2023
Binimetinib and Hydroxychloroquine in Patients With Advanced KRAS Mutant Non-Small Cell Lung Cancer
Principal investigator · Completed · Phase 2
Abramson Cancer Center at Penn Medicine


